Press Release

Whole Genome Sequencing in Type 2 Diabetes Genetic Study

May 9, 2012
Whole Genome Sequencing in Type 2 Diabetes Genetic Study
Complete Genomics sequencing data may help researchers discover new rare type 2 diabetes genetic variants in Mexican-American families
MOUNTAIN VIEW, Calif. – May 9, 2012 – Complete Genomics Inc. (NASDAQ: GNOM) announced today that it has sequenced the genomes of 600

Read More

Complete Genomics Builds Asia-Pacific Presence, Signs Distributor Agreements in Australia, China, Japan and Korea

May 8, 2012
Complete Genomics Builds Asia-Pacific Presence, Signs Distributor Agreements in Australia, China, Japan and Korea
New Distributors Will Ship DNA Samples to Complete Genomics for Sequencing
MOUNTAIN VIEW, Calif. – May 8, 2012 – Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, today announced that it has signed

Read More

Complete Genomics Launches; Becomes World’s First Large-scale Human Genome Sequencing Company

The company, which was established in March 2006, has been operating in “stealth mode” from a 32,000 sq. ft. facility near San Francisco, California. For the past 2.5 years, Complete Genomics has been reinventing the process of DNA sequencing based on pioneering technology invented by its founders and refined by a team of 100 employees with expertise in DNA engineering, molecular biology, instrumentation, semiconductors and high-performance computing.